This role is accountable for shaping and driving the end-to-end strategy for a defined indication or disease area within the Cell Therapy Enterprise.
Base: $270,224 to $405,332; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program eligible; Benefits: 401(k), paid vacation, holidays, leaves, medical, dental, vision
Must-have
Nice-to-have
Not specified